We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Multiplex PCR Platform Detects 21 Common Respiratory Organisms

By LabMedica International staff writers
Posted on 01 Feb 2010
A user-friendly multiplex polymerase chain reaction (PCR) platform is capable of detecting 21 common respiratory viruses and bacteria.

The FilmArray is simplified molecular testing; easy-to-use, the massive multiplex PCR turns a sample into results in less than 1 hour. More...
It requires only 5 minutes of hands-on time.

A product of Idaho Technology (ITI; Salt Lake City, UT, USA), the FilmArray integrates sample preparation, amplification, detection, and analysis into one system that is fully automated and is capable of rapidly detecting more than 100 targets in one sample.

Clinical trials of the FilmArray RP will be conducted at the Children's Medical Center (Dallas, TX, USA) in association with University of Texas (UT) Southwestern Medical Center, (Dallas, TX, USA); the Detroit Medical Center, (Detroit, MI, USA); and the Medical University of South Carolina (Charleston, SC, USA).

Nasopharyngeal swab specimens from 1,000 patients will be tested using the FilmArray RP and compared to results from conventional as well as other molecular diagnostic technologies. If that the trials are successful, the company will submit a 510k application to the US Food and Drug Administration (FDA; Silver Spring, MD, USA) for use of the FilmArray RP as an in vitro diagnostic (IVD) product for patients with symptoms of upper respiratory tract infection.

Kirk Ririe, CEO of Idaho Technology said, "The FilmArray RP is a powerful molecular diagnostic assay designed for comprehensive detection of common respiratory pathogens, and yet is still incredibly simple and easy to use," said Kirk Ririe, CEO of Idaho Technology.

Idaho Technology, Inc. licensed the rapid PCR technology from the University of Utah (Salt Lake City, UT, USA). The company has created many commercial instruments and reagents for use in applied and research fields. Several of these products, including the LightCycler Instrument, have been sublicensed to Roche Diagnostics (Basel, Switzerland). Laboratory personnel, researchers, law enforcement officers, and soldiers in the field use the company's devices to detect or study disease-causing organisms.

Related Links:

Idaho Technology
Children's Medical Center
UT Southwestern Medical Center
Detroit Medical Center
Medical University of South Carolina
US Food and Drug Administration
Roche Diagnostics



Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Collection and Transport System
PurSafe Plus®
New
Capillary Blood Collection Tube
IMPROMINI M3
New
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The VENTANA HER2 (4B5) test is now CE-IVDR approved (Photo courtesy of Roche)

Companion Diagnostic Test Identifies HER2-Ultralow Breast Cancer and Biliary Tract Cancer Patients

Breast cancer is the most common cancer in Europe, with more than 564,000 new cases and 145,000 deaths annually. Metastatic breast cancer is rising in younger populations and remains the leading cause... Read more

Pathology

view channel
Image: An adult fibrosarcoma case report has shown the importance of early diagnosis and targeted therapy (Photo courtesy of Sultana and Sailaja/Oncoscience)

Accurate Pathological Analysis Improves Treatment Outcomes for Adult Fibrosarcoma

Adult fibrosarcoma is a rare and highly aggressive malignancy that develops in connective tissue and often affects the limbs, trunk, or head and neck region. Diagnosis is complex because tumors can mimic... Read more

Technology

view channel
Image: Conceptual design of the CORAL capsule for microbial sampling in the small intestine (H. Mohammed et al., Device (2025). DOI: 10.1016/j.device.2025.100904)

Coral-Inspired Capsule Samples Hidden Bacteria from Small Intestine

The gut microbiome has been linked to conditions ranging from immune disorders to mental health, yet conventional stool tests often fail to capture bacterial populations in the small intestine.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.